VICI's 25% sell-off draws a bullish rebuttal, but the core thesis remains unchanged

What happened

VICI shares have fallen about 19% over the past year and sit near 52-week lows around $26, despite stable operations and raised FY2026 AFFO guidance. The decline intensified after the Caesars-Fertitta acquisition announcement and speculation that MGM might also go private, prompting a Seeking Alpha author to argue the market "overpanicked" and to double down on the stock. That article claims tenant risks are "overblown" and privatization could be an opportunity, but provides no new data beyond pointing to the magnitude of the sell-off. The DeepValue master report already anticipated these concerns, noting that two tenants supply ~70% of rent and that Caesars sale adds uncertainty, though it still rates VICI a POTENTIAL BUY at $26.40 with base value $29. The situation has not fundamentally changed: the focus remains on refinancing 2026 debt and confirming rent contributions from recent acquisitions, while the article simply reflects one bullish investor's view amid a broader sentiment shift.

Implication

For investors already holding VICI, the article's doubling down may be reassuring but should not override the identified risks: refinancing costs above legacy coupons and potential Caesars regional deterioration are live threats. The master report's base case remains $29, with a bear case of $23 if refinancing erodes AFFO growth, so the risk/reward at $26.4 is mildly positive but not compelling enough for a large position. Key near-term checkpoints include disclosure of funding for $500M due Sept 2026 and $1.25B due Dec 2026, and visible rent contributions from Golden and Northfield, which will either confirm or break the thesis. The article's claim that privatization is an "opportunity" lacks supporting analysis; a change in controlling ownership could lead to more aggressive lease negotiations, so investors should demand evidence rather than accept the assertion. Overall, maintain a cautious but constructive stance: add only on weakness toward $25 or upon clear refinancing and AFFO confirmation, while trimming if the stock rallies toward $30 without such confirmation.

Thesis delta

No material change. The article echoes existing bullish arguments but does not address the key risk of refinancing or provide new evidence on tenant stability. The thesis remains a POTENTIAL BUY at $26.40, contingent on refinancing terms and Caesars commentary.